Avidien has secured a new financing round of USD4 million from BroadOak Capital Partners.
Avidien has secured a new financing round of USD4 million from BroadOak Capital Partners.
The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients.
Avidien’s flagship product, the microPro 300, provides precision semi-automated 96 and 384 channel pipetting to hundreds of biotech, medical testing, and research laboratories worldwide.
BroadOak Capital Partners is a life sciences focused financial institution with a track record of supporting companies at the forefront of major industry trends.
Bryan Poltilove, Operating Partner at BroadOak Capital Partners is also joining Avidien’s Board of Directors to guide the company’s next phase of business expansion.
